SOPHiA GENETICS builds the AI-driven, cloud-powered SOPHiA DDM platform, turning multimodal data into clinical and research insights for cancer and rare inherited disorders.
SOPHiA GENETICS develops SOPHiA DDM, an AI-driven, cloud-powered technology platform that turns complex multimodal data into clinical and research insights. The platform is used by clinicians, researchers and biopharma to support diagnosis and treatment in cancer and rare inherited disorders. It distils data into actionable, real-time outputs within clinical and research workflows.
The company was founded in 2011. Its platform is deployed across a network of more than 800 healthcare institutions in over 70 countries. Technical work spans artificial intelligence and machine learning, cloud computing, genomics and bioinformatics, precision-medicine data analytics and multimodal data processing.
SOPHiA GENETICS operates in healthcare and clinical diagnostics, oncology, rare inherited disorders, biopharma and clinical research. The company was founded by biologists seeking to apply technology to medical problems, and frames its work around the aim of democratizing data-driven medicine and widening access to precision medicine globally.
